Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells

Cancer Cell International

Volumn 7, Issue , 2007, Pages

  Honma, Kimi ^a,b   Miyata, Teruo ^b   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Koken Bioscience Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; GENE CLUSTER; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR SUPPRESSOR GENE;

EID: 34547471695     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-7-12     Document Type: Article

References (56)

1. Akamatsu H Ichihara-Tanaka K Ozono K Kamiike W Matsuda H Sekiguchi K Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin Cancer Res 1996 56 4541-4546 8813154
2. Ortega N Werb Z New functional roles for non-collagenaous domains of basement membrane collages J Cell Sci 2002 115 4201-4204 10.1242/ jcs.00106 12376553
3. Clamp AR Jayson GC The clinical potential of antiangiogenic fragments of extracellular matrix proteins Br J Cancer 2005 93 967-972 10.1038/ sj.bjc.6602820 16234821
4. O'Reilly MS Boehm T Shing Y Fukai N Vasios G Lane WS Flynn E Birkhead JR Olsen BR Folkman J Endostatin: An endogenous inhibitor of angiogenesis and tumor growth Cell 1997 88 277-285 10.1016/S0092-8674(00)81848-6 9008168
5. Ramchandran R Dhanabal M Volk R Waterman MJF Segal M Lu H Knebelmann B Sukhatme VP Antiangiogenic activity of restin, NC10 domain of human collagen XV: Comparison to endostatin Biochem Biophys Res Commun 1999 255-735 739 10.1006/bbrc.1999.0248 10049780
6. Sasaki T Larsson H Tisi D Claesson-Welsh L Hohenester E Timpl R Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity J Mol Biol 2000 301 1179-1190 10.1006/jmbi.2000.3996 10966814
7. Colorado PC Torre A Kamphaus G Maeshima Y Hopfer H Takahashi K Volk R Zamborsky ED Herman S Sarkar PK Anti-angiogenic cues from vascular basement membrane collagen Cancer Res 2000 60 2520-2526 10811134
8. Kamphaus GD Colorado PC Panka DJ Hopfer H Ramchandran R Torre A Maeshima Y Mier JW Sukhatme VP Kalluri R Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth J Biol Chem 2000 275 1209-1215 10.1074/jbc.275.2.1209 10625665
9. Maeshima Y Manfredi M Reimer C Holthaus KA Hopfer H Chandamuri BR Kharbanda S Kalluri R Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin J Biol Chem 2001 276 15240-15248 10.1074/jbc.M007764200 11278365
10. Hamano Y Kalluri R Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth Biochem Biophys Res Commun 2005 333 292-298 10.1016/j.bbrc.2005.05.130 15979458
11. Lima E Silva R Kachi S Akiyama H Shen J Aslam S Yuan Gong Y Khu NH Hatara MC Boutaud A Peterson R Campochiaro PA Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis J Cell Physiol 2006 208 161-166 10.1002/jcp.20645 16557520
12. Adams S Sobel ME Howard B Olden K Yamada KM de Crombrugghe B Pastn I Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts Proc Natl Acad Sci USA 1977 74 3399-3403 431579 198783 10.1073/pnas.74.8.3399
13. Sandmeyer S Bornstein P Declining procollagen mRNA sequence in chick embryo fibroblast infected with Rous sarcoma virus J Biol Chem 1979 254 4950-4953 221454
14. Vaheri A Kirkinen M Lehto VP Linder E Timpl R Codistribution of pericellular matrix proteins in cultured fibroblasts and loss of transfomation: Fibronectin and procollagen Proc Natl Acad Sci USA 1976 75 4944-4948 10.1073/pnas.75.10.4944
15. Tannapfel A Anhalt K Hausermann P Sommerer F Benicke M Uhlmann D Witzigmann H Hauss J Wittekind C Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays J Pathol 2003 201 238-249 10.1002/path.1420 14517841
16. DeClerck YA Bomann ET Spengler BA Biedler JL Differential collagen biosynthesis by human neuroblastoma cell variants Cancer Res 1987 47 6505-6510 2445473
17. Rutka JT Giblin JR Apodaca G DeArmond SJ Stern R Rosenblum ML Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins Cancer Res 1987 47 3515-3522 3555773
18. Savaraj N Wu C Landy H Wangpaijit M Wei Y Kuo MT Robles C Furst AJ Lampidis T Feun L Procollagen alpha 1 type 1: A potential aide in histopathological grading of glioma Cancer Invest 2005 23 577-581 10.1080/07357900500276915 16305983
19. Tysnes BB Mahesparan R Biological mechanisms of glioma invasion and potential therapeutic targets J Neurooncol 2001 53 129-147 10.1023/ A:1012249216117 11716066
20. Stander M Naumann U Dumitrescu L Heneka M Loschmann P Gulbins E Dichgans J Weller M Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo Gene Ther 1998 5 1187-1194 10.1038/sj.gt.3300709 9930319
21. Bouterfa H Darlapp AR Klein E Pietsch T Roosen K Tonn JC Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions J Neurooncol 1999 44 23-33 10.1023/A:1006331416283 10582665
22. Mahesparan R Read TA Lund-Johansen M Skaftnesmo KO Bjerkvig R Engebraaten O Expression of extracellular matrix components in a highly infiltrative in vivo glioma model Acta Neuropathol (Berl) 2003 105 49-57 12471461
23. Khazenzon NM Ljubimov AV Lakhter AJ Fujita M Fujiwara H Sekiguchi K Sorokin LM Petajaniemi N Virtanen I Black KL Ljubimova JY Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro Mol Cancer Ther 2003 2 985-994 14578463
24. Hikawa T Mori T Abe T Hori S The ability in adhesion and invasion of drug-resistant human glioma cells J Exp Clin Cancer Res 2000 19 357-362 11144529
25. Tews DS Adhesive and invasive features in gliomas Pathol Res Pract 2000 196 701-711 11087057
26. Utsuki S Sato Y Oka H Tsuchiya B Suzuki S Fujii K Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas J Neurooncol 2002 57 187-192 10.1023/A:1015720220602 12125981
27. Asano K Kubo O Tajika Y Huang MC Takakura K Ebina K Suzuki S Expression androle of cadherins in astrocytic tumors Brain Tumor Pathol 1997 14 27-33 10.1007/BF02478865 9384799
28. Shinoura N Paradies NE Warnick RE Chen H Larson JJ Tew JJ Simon M Lynch RA Kanai Y Hirohashi S Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas Br J Cancer 1995 72 627-33 7669572
29. Asano K Duntsch CD Zhou Q Weimar JD Bordelon D Robertson JH Pourmotabbed T Correlation of N-cadherin expression in high grade gliomas with tissue invasion J Neurooncol 2004 70 3-15 10.1023/B:NEON.0000040811.14908.f2 15527101
30. Munz C Naumann U Grimmel C Rammensee HG Weller M TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells Eur J Immunol 1999 29 1032-1040 10.1002/ (SICI)1521-4141(199903)29:03<1032::AID-IMMU1032>3.0.CO;2-W 10092108
31. Engel S Isenmann S Stander M Rieger J Bahr M Weller M Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration J Neuroimmunol 1999 99 13-18 10.1016/S0165-5728(99)00062-4 10496172
32. Roth JM Akalu A Zelmanovich A Policarpio D Ng B MacDonald S Formenti S Liebes L Brooks PC Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo Am J Pathol 2005 166 901-911 1602358 15743801
33. He GA Luo JX Zhang TY Wang FY Li RF Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth Biochem Biophys Res Commun 2003 312 801-805 10.1016/j.bbrc.2003.11.003 14680836
34. He GA Luo JX Zhang TY Hu ZS Wang FY The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells Biochem Biophys Res Commun 2004 318 354-360 10.1016/ j.bbrc.2004.04.038 15120609
35. Panka DJ Mier JW Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells J Biol Chem 2003 278 37632-37636 10.1074/jbc.M307339200 12876280
36. Sudhakar A Sugimoto H Yang C Lively J Zeisberg M Kalluri R Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins Proc Natl Acad Sci USA 2003 100 4766-4771 153630 12682293 10.1073/ pnas.0730882100
37. Boehm T Folkman J Browder T O'Reilly MS Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 1997 390 404-407 10.1038/37126 9389480
38. Sorensen DR Read TA Porwol T Olsen BR Timpl R Sasaki T Iversen PO Benestad HB Sim BK Bjerkvig R Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma Neuro-oncol 2002 4 1-8 10.1215/ 15228517-4-1-1 11772427
39. Kim YM Jang JW Lee OH Yeon J Choi EY Kim KW Lee ST Kwon YG Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase Cancer Res 2000 60 5410-5413 11034081
40. Lee SJ Jang JW Kim YM Lee HI Jeon JY Kwon YG Lee ST Endostatin binds to the catalytic domain of matrix metalloproteinase-2 FEBS Lett 2002 519 147-152 10.1016/S0014-5793(02)02742-4 12023034
41. Nyberg P Heikkila P Sorsa T Luostarinen J Heljasvaara R Stenman UH Pihlajaniemi T Salo T Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13 J Biol Chem 2003 278 22404-22411 10.1074/ jbc.M210325200 12690120
42. Dhanabal M Ramchandran R Waterman MJ Lu H Knebelmann B Segal M Sukhatme VP Endostatin induces endothelial cell apoptosis J Biol Chem 1999 274 11721-11726 10.1074/jbc.274.17.11721 10206987
43. Yokoyama Y Dhanabal M Griffioen AW Sukhatme VP Ramakrishnan S Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth Cancer Res 2000 60 2190-2196 10786683
44. Dkhissi F Lu H Soria C Opolon P Griscelli F Liu H Khattar P Mishal Z Perricaudet M Li H Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells Hum Gene Ther 2003 14 997-1008 10.1089/104303403766682250 12869217
45. Shinoura N Hamada H Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells Curr Gene Ther 2003 3 147-153 10.2174/ 1566523034578410 12653407
46. Puduvalli VK Sawaya R Antiangiogenesis-therapeutic strategies and clinical implications for brain tumors J Neurooncol 2000 50 189-200 10.1023/A:1006469830739 11245279
47. Jansen M de Witt Hamer PC Witmer AN Troost D van Noorden CJ Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas Brain Res Brain Res Rev 2004 45 143-163 10.1016/ j.brainresrev.2004.03.001 15210301
48. De Bouard S Guillamo JS Christov C Lefevre N Brugieres P Gola E Devanz P Indraccolo S Peschanski M Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin Hum Gene Ther 2003 14 883-895 10.1089/104303403765701178 12828859
49. Ehtesham M Black KL Yu JS Recent progress in immunotherapy for malignant glioma: Treatment strategies and results from clinical trials Cancer Control 2004 11 192-207 15153843
50. Peroulis I Jonas N Saleh M Antiangiogenic activity of endostatin inhibits C6 glioma growth Int J Cancer 2002 97 839-845 10.1002/ijc.10115 11857365
51. Pulkkanen KJ Laukkanen JM Fuxe J Kettunen MI Rehn M Kannasto JM Parkkinen JJ Kauppinen RA Pettersson RF Yla-Herttuala S The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice Cancer Gene Ther 2002 9 908-916 10.1038/ sj.cgt.7700519 12386829
52. Visted T Lund-Johansen M rogress and challenges for cell encapsulation in brain tumour therapy Expert Opin Biol Ther 2003 3 551-561 10.1517/ 14712598.3.4.551 12831361
53. Ohlfest JR Demorest ZL Motooka Y Vengco I Oh S Chen E Scappaticci FA Saplis RJ Ekker SC Low WC Freese AB Largaespada DA Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma Mol Ther 2005 12 778-788 10.1016/ j.ymthe.2005.07.689 16150649
54. Barnett FH Scharer-Schuksz M Wood M Yu X Wagner TE Friedlander M Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure Gene Ther 2004 11 1283-1289 10.1038/sj.gt.3302287 15164099
55. Rubenstein M Shaw M Mirochnik Y Slobodskoy L Glick R Lichtor T Chou P Guinan P In vivo establishment of T98G human glioblastoma Methods Find Exp Clin Pharmacol 1999 21 391-393 10.1358/mf.1999.21.6.541918 10445230
56. Teicher BA Menon K Alvarez E Galbreath E Shih C Faul M Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts Clin Cancer Res 2001 7 634-640 11297259